CMOTEC_B: 2024 saw record sales, improved results, and strong Animal Care growth, supporting future expansion

About this update from Scandinavian Chemotech Ab Class B

Record revenue in 2024 driven by Animal Care, improved operating results, and strategic expansion in key markets. Loan restructuring and new orders support a positive outlook for 2025. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Chemotech Ab Class B